Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Radiother Oncol ; 195: 110267, 2024 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-38614282

RESUMO

BACKGROUND AND PURPOSE: Medulloblastoma (MB) is a common primary brain cancer in children. Proton therapy in pediatric MB is intensively studied and widely adopted. Compared to photon, proton radiations offer potential for reduced toxicity due to the characteristic Bragg Peak at the end of their path in tissue. The aim of this study was to compare the effects of irradiation with the same dose of protons or photons in Patched1 heterozygous knockout mice, a murine model predisposed to cancer and non-cancer radiogenic pathologies, including MB and lens opacity. MATERIALS AND METHODS: TOP-IMPLART is a pulsed linear proton accelerator for proton therapy applications. We compared the long-term health effects of 3 Gy of protons or photons in neonatal mice exposed at postnatal day 2, during a peculiarly susceptible developmental phase of the cerebellum, lens, and hippocampus, to genotoxic stress. RESULTS: Experimental testing of the 5 mm Spread-Out Bragg Peak (SOBP) proton beam, through evaluation of apoptotic response, confirmed that both cerebellum and hippocampus were within the SOBP irradiation field. While no differences in MB induction were observed after irradiation with protons or photons, lens opacity examination confirmed sparing of the lens after proton exposure. Marked differences in expression of neurogenesis-related genes and in neuroinflammation, but not in hippocampal neurogenesis, were observed after irradiation of wild-type mice with both radiation types. CONCLUSION: In-vivo experiments with radiosensitive mouse models improve our mechanistic understanding of the dependence of brain damage on radiation quality, thus having important implications in translational research.


Assuntos
Animais Recém-Nascidos , Apoptose , Hipocampo , Fótons , Terapia com Prótons , Animais , Camundongos , Apoptose/efeitos da radiação , Terapia com Prótons/efeitos adversos , Hipocampo/efeitos da radiação , Meduloblastoma/radioterapia , Meduloblastoma/patologia , Carcinogênese/efeitos da radiação , Camundongos Knockout , Neoplasias Cerebelares/radioterapia , Neoplasias Cerebelares/patologia , Encéfalo/efeitos da radiação , Receptor Patched-1/genética , Modelos Animais de Doenças , Prótons/efeitos adversos
2.
Radiat Prot Dosimetry ; 180(1-4): 360-364, 2018 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-29053837

RESUMO

The TOP-IMPLART, a new proton therapy facility, is under development in Frascati ENEA Laboratories, near Rome. The project is centered on a medium-energy proton accelerator designed as a sequence of modular linear accelerators (the final energy will be 230 MeV). Being not a commercial product, measurements and simulation are fundamental to characterize the system and the radiation field, even during its construction. In this work some preliminary evaluations of the neutron contamination have been tried. The simulations were validated through some measurements obtaining a satisfactory agreement. A more detailed calculations and measurements campaign is scheduled for the next future.


Assuntos
Arquitetura de Instituições de Saúde , Nêutrons , Aceleradores de Partículas/instrumentação , Terapia com Prótons/instrumentação , Terapia com Prótons/métodos , Simulação por Computador , Humanos , Método de Monte Carlo , Proteção Radiológica , Dosagem Radioterapêutica
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA